As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback